Andreas Menrad

PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.

J M Wood, Guido Bold, Elisabeth Buchdunger et al. · PubMed · 2000 · 846 citations

Immunology, Oral Administration, Pharmacotherapy +20

Expression of the oncofetal ED-B–containing fibronectin isoform in hematologic tumors enables ED-B–targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients

Stefanie Sauer, Paola Anna Erba, Mario Petrini et al. · Blood · 2009 · 170 citations

Involvement of hepatocyte growth factor/scatter factor and Met receptor signaling in hair follicle morphogenesis and cycling

G Lindner, Andreas Menrad, Ermanno Gherardi et al. · The FASEB Journal · 2000 · 138 citations

Hair Follicle Morphogenesis, Skin Development, Developmental Biology +14

Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.

Gerhard Siemeister, Michael Schirner, Karin Weindel et al. · PubMed · 1999 · 137 citations

Tyrosine Kinase, Immunology, Tie-2 Pathway +17

Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells.

Andreas Menrad, David W. Speicher, J Wacker et al. · PubMed · 1993 · 136 citations

Glycobiology, Melanoma Cells, Tumor Biology +17